Expression of muscarinic M1 and M2 receptors in the anterior cingulate cortex associated with neuropathic pain.
Ortega-Legaspi
J Manuel
JM
Laboratorio de Neurofisiología Integrativa, Dirección de Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente, Mexico.
León-Olea
Martha
M
de Gortari
Patricia
P
Amaya
María Isabel
MI
Coffeen
Ulises
U
Simón-Arceo
Karina
K
Pellicer
Francisco
F
D000818:Animals; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D006179:Gyrus Cinguli / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D010146:Pain / Q000188:drug therapy / Q000378:metabolism*; D010147:Pain Measurement / Q000379:methods; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D043643:Receptor, Muscarinic M1 / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D043585:Receptor, Muscarinic M2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D012601:Scopolamine / Q000494:pharmacology*
D018727:Muscarinic Antagonists; D012333:RNA, Messenger; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; D012601:Scopolamine